Author:
Dharmalingam Mala,Aravind S. R.,Thacker Hemant,Paramesh S.,Mohan Brij,Chawla Manoj,Asirvatham Arthur,Goyal Ramesh,Shembalkar Jayashri,Balamurugan R.,Kadam Pradnya,Alva Hansraj,Kodgule Rahul,Tandon Monika,Vaidyanathan Sivakumar,Pendse Amol,Gaikwad Rajesh,Katare Sagar,Suryawanshi Sachin,Barkate Hanmant
Funder
Glenmark Pharmaceuticals Limited.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels: International Diabetes Federation. 2017. http://www.diabetesatlas.org. Accessed 27 July 2019.
2. Rojas LB, Gomes MB. Metformin: an old but still the best treatment for type 2 diabetes. Diabetol Metab Syndr. 2013;5:6.
3. International Diabetes Federation Global guideline for type 2 diabetes. http://www.idf.org/global-guideline-type-2-diabetes-2012. Accessed 5 Sep 2013.
4. National Institute for Health and Clinical Excellence Type 2 diabetes: The management of type 2 diabetes (NICE clinical guideline 87). http://www.nice.org.uk/guidance/CG87. Accessed 15 Aug 2013.
5. Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab Syndr Obes. 2014;7:15–24.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献